Adlai Nortye Ltd. (ANL)
NASDAQ: ANL · Real-Time Price · USD
8.18
+0.28 (3.54%)
At close: Apr 2, 2026, 4:00 PM EDT
8.24
+0.06 (0.73%)
After-hours: Apr 2, 2026, 7:54 PM EDT
Adlai Nortye Market Cap
Adlai Nortye has a market cap or net worth of $301.84 million as of April 2, 2026. Its market cap has increased by 257.21% in one year.
Market Cap
301.84M
Enterprise Value
302.27M
1-Year Change
257.21%
Ranking
Category
Stock Price
$8.18
Market Cap Chart
Since the IPO on September 29, 2023, Adlai Nortye's market cap has decreased from $553.50M to $301.84M, a decrease of -45.47%. That is a compound annual growth rate of -21.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 2, 2026 | 301.84M | 476.06% |
| Dec 31, 2025 | 52.40M | -47.12% |
| Dec 31, 2024 | 99.08M | -70.13% |
| Dec 29, 2023 | 331.73M | -40.07% |
| Sep 29, 2023 | 553.50M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Opus Genetics | 323.73M |
| Neurogene | 322.23M |
| Surrozen | 320.13M |
| Greenwich LifeSciences | 316.16M |
| Palisade Bio | 313.52M |
| Climb Bio | 313.36M |
| Inhibikase Therapeutics | 306.76M |
| LENZ Therapeutics | 303.20M |